Literature DB >> 17035415

No association between serum insulin-like growth factor (IGF)-I, IGF-binding protein-3, and lung cancer risk.

Jiyoung Ahn1, Stephanie J Weinstein, Kirk Snyder, Michael N Pollak, Jarmo Virtamo, Demetrius Albanes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17035415     DOI： 10.1158/1055-9965.EPI-06-0580

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  7 in total

1.  Serum Insulin, Glucose, Indices of Insulin Resistance, and Risk of Lung Cancer.

Authors:  Ilona Argirion; Stephanie J Weinstein; Satu Männistö; Demetrius Albanes; Alison M Mondul
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-11       Impact factor: 4.254

2.  Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.

Authors:  Jin-Soo Kim; Edward S Kim; Diane Liu; J Jack Lee; Luisa Solis; Carmen Behrens; Scott M Lippman; Waun Ki Hong; Ignacio I Wistuba; Ho-Young Lee
Journal:  Clin Lung Cancer       Date:  2014-01-01       Impact factor: 4.785

3.  Insulin-like growth factor-1 receptor-targeted therapy for non-small cell lung cancer: a mini review.

Authors:  Ming Yin; Xiaoxiang Guan; Zhongxin Liao; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-30       Impact factor: 4.060

4.  IGF-I and IGFBP-3 and the risk of lung cancer: a meta-analysis based on nested case-control studies.

Authors:  Bo Chen; Shan Liu; Wei Xu; Xueli Wang; Weihong Zhao; Jianqing Wu
Journal:  J Exp Clin Cancer Res       Date:  2009-06-24

5.  Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis.

Authors:  Hongxin Cao; Guanghui Wang; Long Meng; Hongchang Shen; Zhen Feng; Qi Liu; Jiajun Du
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

Review 6.  Is there a role for IGF-1 in the development of second primary cancers?

Authors:  Thurkaa Shanmugalingam; Cecilia Bosco; Anne J Ridley; Mieke Van Hemelrijck
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

Review 7.  The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer.

Authors:  Alexander W Pohlman; Hita Moudgalya; Lia Jordano; Gabriela C Lobato; David Gerard; Michael J Liptay; Christopher W Seder; Jeffrey A Borgia
Journal:  Oncotarget       Date:  2022-02-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.